China JV - NCPC-Orchid Pharmaceuticals Ltd.
Considering the potential of the Chinese market, Orchid established a manufacturing and marketing joint venture with the North China Pharmaceutical Corporation (NCPC), the largest pharmaceutical group in China.

China is reckoned as one of the most competitive manufacturing bases in the world and is also a fast growing market for pharmaceuticals and the single largest market for Orchid's Cephalosporin products. Given Orchid's strengths in technology and manufacturing and NCPC's wide market presence in China, this venture (NCPC-Orchid) provides Orchid a strong presence in the growing Chinese market.